Selective recognition of bacterial phospholipids by antimicrobial peptides: Employing a host-guest-mediated competitive inhibition strategy

IF 12.8 1区 医学 Q1 ENGINEERING, BIOMEDICAL
Xinshuang Zhang , Dong Luo , Jie Hu , Kangxiu Wu , Shuyi Jia , Xueyi Li , Songyin Huang , Houbing Zhang , Dokyun Kim , Yuzhi Hong , Liping Zhao , Menghua Xiong , Yan Bao
{"title":"Selective recognition of bacterial phospholipids by antimicrobial peptides: Employing a host-guest-mediated competitive inhibition strategy","authors":"Xinshuang Zhang ,&nbsp;Dong Luo ,&nbsp;Jie Hu ,&nbsp;Kangxiu Wu ,&nbsp;Shuyi Jia ,&nbsp;Xueyi Li ,&nbsp;Songyin Huang ,&nbsp;Houbing Zhang ,&nbsp;Dokyun Kim ,&nbsp;Yuzhi Hong ,&nbsp;Liping Zhao ,&nbsp;Menghua Xiong ,&nbsp;Yan Bao","doi":"10.1016/j.biomaterials.2025.123392","DOIUrl":null,"url":null,"abstract":"<div><div>The distinct phospholipid compositions of bacterial and mammalian cell membranes offer a promising target for the development of antimicrobial peptides (AMPs). However, distinguishing between the similarly charged anionic phospholipids—bacterial phosphatidylglycerol (PG) and mammalian phosphatidylserine (PS)—poses a significant challenge. Here we introduce a competitive inhibition strategy that leverages host-guest interactions to enable AMPs to selectively recognize PG without engaging with PS. After analyzing the binding interactions of various radially amphiphilic AMPs (RAPs), host molecules, and phospholipids, we discovered that a RAP, named C6HO, exhibited a higher affinity for cucurbit[7]uril (CB[7]) compared to PS, yet a lower affinity than for PG. Consequently, CB[7] functions as a competitive inhibitor: by forming a complex with C6HO upon simple mixing, it prevents C6HO from interacting with PS. Notably, PG can outcompete CB[7] for binding to C6HO within the complex, leading to the aggregation of PG molecules and the subsequent disruption of membranes rich in PG. Furthermore, the competitive inhibitor CB[7] effectively neutralizes C6HO's cytotoxic effects on mammalian cells while preserving the antimicrobial potency of C6HO. In vivo experiments in a subcutaneous infection model demonstrated that CB[7] reduced both systemic and local toxicity of C6HO without compromising its antimicrobial efficacy. Our study presents a strategy for the specific recognition of bacterial phospholipids and the design of highly selective AMPs.</div></div>","PeriodicalId":254,"journal":{"name":"Biomaterials","volume":"322 ","pages":"Article 123392"},"PeriodicalIF":12.8000,"publicationDate":"2025-05-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomaterials","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0142961225003114","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

The distinct phospholipid compositions of bacterial and mammalian cell membranes offer a promising target for the development of antimicrobial peptides (AMPs). However, distinguishing between the similarly charged anionic phospholipids—bacterial phosphatidylglycerol (PG) and mammalian phosphatidylserine (PS)—poses a significant challenge. Here we introduce a competitive inhibition strategy that leverages host-guest interactions to enable AMPs to selectively recognize PG without engaging with PS. After analyzing the binding interactions of various radially amphiphilic AMPs (RAPs), host molecules, and phospholipids, we discovered that a RAP, named C6HO, exhibited a higher affinity for cucurbit[7]uril (CB[7]) compared to PS, yet a lower affinity than for PG. Consequently, CB[7] functions as a competitive inhibitor: by forming a complex with C6HO upon simple mixing, it prevents C6HO from interacting with PS. Notably, PG can outcompete CB[7] for binding to C6HO within the complex, leading to the aggregation of PG molecules and the subsequent disruption of membranes rich in PG. Furthermore, the competitive inhibitor CB[7] effectively neutralizes C6HO's cytotoxic effects on mammalian cells while preserving the antimicrobial potency of C6HO. In vivo experiments in a subcutaneous infection model demonstrated that CB[7] reduced both systemic and local toxicity of C6HO without compromising its antimicrobial efficacy. Our study presents a strategy for the specific recognition of bacterial phospholipids and the design of highly selective AMPs.
抗菌肽对细菌磷脂的选择性识别:采用主客介导的竞争性抑制策略
细菌和哺乳动物细胞膜中不同的磷脂组成为抗菌肽(AMPs)的开发提供了一个有希望的靶点。然而,区分带类似电荷的阴离子磷脂——细菌磷脂酰甘油(PG)和哺乳动物磷脂酰丝氨酸(PS)——是一个重大挑战。在此,我们引入了一种竞争抑制策略,利用宿主-客体相互作用,使amp选择性地识别PG而不与PS结合。在分析了各种径向两亲性amp (RAP)、宿主分子和磷脂的结合相互作用后,我们发现,一种名为C6HO的RAP对葫芦bb[7] (CB[7])的亲和力比PS高,但对PG的亲和力低于PS。因此,CB[7]是一种竞争抑制剂。通过与C6HO简单混合形成复合物,可以阻止C6HO与PS相互作用。值得注意的是,PG可以在复合物内与CB[7]结合,导致PG分子聚集并随后破坏富含PG的膜。此外,竞争性抑制剂CB[7]有效地中和了C6HO对哺乳动物细胞的细胞毒性作用,同时保留了C6HO的抗菌活性。皮下感染模型的体内实验表明,CB[7]可降低C6HO的全身和局部毒性,而不影响其抗菌功效。我们的研究提出了一种特异性识别细菌磷脂和设计高选择性amp的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Biomaterials
Biomaterials 工程技术-材料科学:生物材料
CiteScore
26.00
自引率
2.90%
发文量
565
审稿时长
46 days
期刊介绍: Biomaterials is an international journal covering the science and clinical application of biomaterials. A biomaterial is now defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic procedure. It is the aim of the journal to provide a peer-reviewed forum for the publication of original papers and authoritative review and opinion papers dealing with the most important issues facing the use of biomaterials in clinical practice. The scope of the journal covers the wide range of physical, biological and chemical sciences that underpin the design of biomaterials and the clinical disciplines in which they are used. These sciences include polymer synthesis and characterization, drug and gene vector design, the biology of the host response, immunology and toxicology and self assembly at the nanoscale. Clinical applications include the therapies of medical technology and regenerative medicine in all clinical disciplines, and diagnostic systems that reply on innovative contrast and sensing agents. The journal is relevant to areas such as cancer diagnosis and therapy, implantable devices, drug delivery systems, gene vectors, bionanotechnology and tissue engineering.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信